Eisai Co. and its subsidiaries are engaged in the manufacture and sale of pharmaceuticals, consumer health care products, diagnostic products, chemicals and food additives, and animal health products. Co. s products include antiallergy agent, osteoporosis treatment, gastritis/gastric ulcer medication, vitamins, food preservative, flavoring agent, and sweetening material. Co. is also engaged in the manufacture and sale of pharmaceutical production system and machines.
Quote | Eisai Co Ltd (OTCMKTS:ESALF)
Last: | $43.85 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $43.85 |
High: | $0 |
Low: | $0 |
Volume: | 80 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Eisai Co Ltd (OTCMKTS:ESALF)
"LEQEMBI" Lecanemab) Approved for the Treatment of Alzheimer's Disease in Israel TOKYO and CAMBRIDGE, Mass., July 12, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody "LEQEMB...
2024-07-11 11:42:26 ET Summary Biogen Inc.'s shares have risen 20% since its first quarter earnings report, with hopes for new product launches to boost revenue. However, its Alzheimer's medicine, Leqembi, now faces new competition from Eli Lilly, and its MS franchise has various ...
Message Board Posts | Eisai Co Ltd (OTCMKTS:ESALF)
Subject | By | Source | When |
---|---|---|---|
is it bear time? Or do we go bull? | stocktrademan | investorshub | 06/25/2023 9:15:45 PM |
$ESALF recent news/filings | stocktrademan | investorshub | 07/21/2015 5:37:47 PM |
Stock_Tracker: Latest Eisai Co Ltd (ESALF) Headlines Arterial Thrombosis - Pipeline Review, H2 2013 | Stock_Tracker | investorshangout | 03/09/2014 10:43:46 PM |
chartguy89: ESALF 38.75 Stock Charts $ESALF 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 7:59:58 AM |
chartguy89: ESALF Stock Charts Last: +1.20 Wednesday, February 26, 2014 at 12:11:28 AM $ESALF | chartguy89 | investorshangout | 02/26/2014 5:11:39 AM |
News, Short Squeeze, Breakout and More Instantly...
Eisai Co Ltd Company Name:
ESALF Stock Symbol:
OTCMKTS Market:
"LEQEMBI" Lecanemab) Approved for the Treatment of Alzheimer's Disease in Israel TOKYO and CAMBRIDGE, Mass., July 12, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody "LEQEMB...
"LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Hong Kong TOKYO and CAMBRIDGE, Mass., July 11, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that the Department of Health in HongKong has approved humanized anti-soluble aggregated ...
Eisai Announces Move to Solo Development and Commercialization of Farletuzumab Ecteribulin (FZEC) Antibody Drug Conjugate (ADC) TOKYO, July 2, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has agreed to end its global strategic collaboration with Bristol Myers Squi...